ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 20 filers reported holding ENDOLOGIX INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $12,549,000 | +99.0% | 12,805,000 | +102.3% | 0.01% | +100.0% |
Q2 2018 | $6,306,000 | +59.5% | 6,330,000 | +55.1% | 0.00% | +50.0% |
Q1 2018 | $3,953,000 | +25.7% | 4,080,000 | +25.5% | 0.00% | 0.0% |
Q4 2017 | $3,144,000 | +0.6% | 3,250,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,124,000 | +162.5% | 3,250,000 | +160.0% | 0.00% | +100.0% |
Q2 2017 | $1,190,000 | -39.0% | 1,250,000 | -38.1% | 0.00% | -50.0% |
Q1 2017 | $1,950,000 | -65.3% | 2,020,000 | -67.6% | 0.00% | -66.7% |
Q4 2016 | $5,624,000 | +43.9% | 6,230,000 | +47.6% | 0.01% | +50.0% |
Q2 2016 | $3,907,000 | +25.1% | 4,221,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $3,124,000 | +90.1% | 4,221,000 | +111.0% | 0.00% | +100.0% |
Q4 2015 | $1,643,000 | -84.7% | 2,000,000 | -83.3% | 0.00% | -81.8% |
Q3 2014 | $10,738,000 | -32.6% | 12,000,000 | -24.5% | 0.01% | -38.9% |
Q2 2014 | $15,937,000 | +4.4% | 15,900,000 | 0.0% | 0.02% | 0.0% |
Q1 2014 | $15,269,000 | -0.4% | 15,900,000 | +6.0% | 0.02% | -10.0% |
Q4 2013 | $15,338,000 | – | 15,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|